180 Life Sciences: Funding, Investors & Team (Oct 2026)
180 Life Sciences Corp. is a biotechnology company in the clinical stage, specializing in creating innovative drugs to address gaps in the treatment of inflammatory diseases, fibrosis, and pain. The company draws on the knowledge and expertise of experts in therapeutic medicine from Oxford University, the Hebrew University, and Stanford University.
180 Life Sciences has raised $431M across 3 funding rounds on record, the most recent an undisclosed round of $425M announced in Jul 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
180 Life Sciences Company Profile and Key Stats
Latest funding round on record: Jul 2025.
180 Life Sciences Funding Rounds
180 Life Sciences raised $3.0M in an undisclosed round announced in Aug 2023.
1.3 years later, an undisclosed round of $2.9M was announced in Dec 2024.
7 months later, an undisclosed round of $425M was announced in Jul 2025.
180 Life Sciences Founders and Leadership Team
Contact details for the 180 Life Sciences team: 1 of 1 has an email address on file.
Start 14-day free trial →180 Life Sciences Funding Compared to Other Biotechnology Startups
180 Life Sciences' latest round of $425M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 180 Life Sciences in Biotechnology and Menlo Park
Companies Similar to 180 Life Sciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
180 Life Sciences Funding FAQs
What does 180 Life Sciences do?
180 Life Sciences Corp. is a biotechnology company in the clinical stage, specializing in creating innovative drugs to address gaps in the treatment of inflammatory diseases, fibrosis, and pain. The company draws on the knowledge and expertise of experts in therapeutic medicine from Oxford University, the Hebrew University, and Stanford University.
How much funding has 180 Life Sciences raised?
180 Life Sciences has raised $431M across 3 rounds on record. The most recent is an undisclosed round of $425M announced in Jul 2025.
When did 180 Life Sciences last raise funding?
180 Life Sciences' most recent funding round on record is an undisclosed round of $425M, announced in Jul 2025.
Who founded 180 Life Sciences?
FundedIQ lists Jim Woody (Founder) at 180 Life Sciences.
Where is 180 Life Sciences headquartered?
180 Life Sciences is based in Menlo Park, California, United States.
How many employees does 180 Life Sciences have?
180 Life Sciences is in the 1-10 employee band.
How does 180 Life Sciences' funding compare to other Biotechnology startups?
180 Life Sciences' latest round of $425M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's 180 Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 180 Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.